Human papillomavirus 16 (HPV 16) E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7. Issue 11 (18th September 2020)

• Record Type: Journal Article
• Authors: Hu, Yue; Wu, Ming‐Zhe; Gu, Na‐Jin; Xu, Hong‐Tao; Li, Qing‐Chang; Wu, Guang‐Ping
• Is Part Of: Thoracic cancer. Volume 11:Issue 11(2020)
• Page Start: 3175
• Page End: 3180
• Publication Date: 2020-09-18
• Subjects: Human papillomavirus (HPV) -- kinesin family member 7 (KIF7) -- liver kinase B1 (LKB1) -- lung cancer -- serine/threonine kinase 11 (STK11); Chest -- Cancer -- Periodicals; Chest -- Cancer -- Treatment -- Periodicals; Chest -- Surgery -- Periodicals; 616.99494005
• DOI: 10.1111/1759-7714.13640
• Languages: English
• ISSNs: 1759-7706

Abstract

Abstract : Background: The E6 and E7 proteins in human papillomavirus 16 (HPV 16) are the main oncogenes in the occurrence of lung cancer. In recent studies, we found that E6 and E7 downregulated the expression of LKB1 in lung cancer cells. However, it is still unclear how E6 and E7 regulate LKB1 in lung cancer cells. Methods: Double directional genetic manipulation and nuclear plasma separation technology were performed to explore the molecular mechanism of E6 and E7 inhibiting the antitumor activity of LKB1 in well‐established lung cancer cell lines. Results: E6 but not E7 significantly downregulated the expression of tumor suppressor KIF7 at protein level, and the inhibition of KIF7 further reduced the expression of LKB1 both in the nuclei and in the cytoplasm, whereas reduced the expression of p‐LKB1 in the cytoplasm only. This suggested that HPV 16 E6 but not E7 downregulates the antitumor activity of LKB1 by downregulating the expression of p‐LKB1 in the cytoplasm only. Conclusions: Here, we demonstrated for the first time that E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7. Our findings provide new evidence to support the important role of KIF7 in the pathogenesis of lung cancer and suggests new therapeutic targets. Abstract : We demonstrated for the first time that E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7 and the antitumor activity of LKB1 was determined by two factors, one was phosphorylation of LKB1, the other was that p‐LKB1 must be located in the cytoplasm, both were indispensable.